Read more on ecraid.eu/news/ecraid-...
@lenniederde.bsky.social @advance-id.bsky.social @elskesieswerda.bsky.social @carb-x.bsky.social #AntimicrobialResistance #AMR #AntibioticDevelopment #Antibiotics #InfectiousDiseases #WHO
@lenniederde.bsky.social @advance-id.bsky.social @elskesieswerda.bsky.social @carb-x.bsky.social #AntimicrobialResistance #AMR #AntibioticDevelopment #Antibiotics #InfectiousDiseases #WHO
Ecraid supports WHO Industry Dialogue on Global Antibiotic Development | Ecraid
ecraid.eu
September 4, 2026 at 12:04 PM
On 31 Aug, the @who.int convened 153 participants from industry, academia & regulatory bodies to discuss the challenges of #antibioticdevelopment and solutions.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
September 4, 2026 at 12:04 PM
On 31 Aug, the @who.int convened 153 participants from industry, academia & regulatory bodies to discuss the challenges of #antibioticdevelopment and solutions.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
Ecraid was contribute to the dialogue, and will help develop analyses to support future WHO guidance on #evidencegeneration.
𝐇𝐨𝐰 𝐜𝐚𝐧 𝐞𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐩𝐫𝐢𝐨𝐫𝐢𝐭𝐲 𝐚𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜𝐬 𝐛𝐞𝐭𝐭𝐞𝐫 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐛𝐨𝐭𝐡 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐚𝐧𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐮𝐬𝐞? 🌍 Join the WHO Industry Dialogue with priority antibacterial agent developers to explore the realities of global #antibioticdevelopment and where future WHO guidance could add value.
August 27, 2026 at 12:23 PM
𝐇𝐨𝐰 𝐜𝐚𝐧 𝐞𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐩𝐫𝐢𝐨𝐫𝐢𝐭𝐲 𝐚𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜𝐬 𝐛𝐞𝐭𝐭𝐞𝐫 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐛𝐨𝐭𝐡 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐚𝐧𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐮𝐬𝐞? 🌍 Join the WHO Industry Dialogue with priority antibacterial agent developers to explore the realities of global #antibioticdevelopment and where future WHO guidance could add value.
Thank you everyone for attending last night's BrisJAMS session and our three wonderful speakers for sharing valuable insights into their research.
🔬💡🧫🙌 😎 😁
#MicrobiologyForAll #BacterialInfections #ViralPhylogeny #AntibioticDevelopment #Biofilms #Microbiology2025 #jamsbrisbane
🔬💡🧫🙌 😎 😁
#MicrobiologyForAll #BacterialInfections #ViralPhylogeny #AntibioticDevelopment #Biofilms #Microbiology2025 #jamsbrisbane
September 4, 2025 at 5:12 AM
Thank you everyone for attending last night's BrisJAMS session and our three wonderful speakers for sharing valuable insights into their research.
🔬💡🧫🙌 😎 😁
#MicrobiologyForAll #BacterialInfections #ViralPhylogeny #AntibioticDevelopment #Biofilms #Microbiology2025 #jamsbrisbane
🔬💡🧫🙌 😎 😁
#MicrobiologyForAll #BacterialInfections #ViralPhylogeny #AntibioticDevelopment #Biofilms #Microbiology2025 #jamsbrisbane
#antibioticresistance #AMR #antibioticresistancecrisis #antimicrobialresearch #antibioticdevelopment #preventiveantimicrobials #antiinfectivedrugs #patientoutcomes #bacterialinfection #hospitalacquiredinfections #monoclonalantibodies #biologicpreventives
magazine.pharmatimes.com/collections/...
magazine.pharmatimes.com/collections/...
28-29 ANTIBIOTICS - Changing the script
As the cover so boldly suggests, we’re talking ‘women in pharma’. Progress, ambitions, direction, understanding and essence. Indeed, this edition focuses on the dimensions of difference that only wome...
magazine.pharmatimes.com
April 14, 2025 at 8:50 AM